share_log

Cardio Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer Dogan Timur

Cardio Diagnostics | 4:持股變動聲明-高管 Dogan Timur

SEC announcement ·  02/22 04:02
牛牛AI助理已提取核心訊息
Cardio Diagnostics Holdings, Inc. (CDIO.US) has reported a transaction involving Chief Technology Officer Timur Dogan. The transaction took place on January 23, 2024. However, the specific details regarding the number of shares, nature of shares, transaction price, and the total value of shares involved in the transaction were not disclosed in the announcement. The current number of shares held by Dogan after the transaction also remains undisclosed.
Cardio Diagnostics Holdings, Inc. (CDIO.US) has reported a transaction involving Chief Technology Officer Timur Dogan. The transaction took place on January 23, 2024. However, the specific details regarding the number of shares, nature of shares, transaction price, and the total value of shares involved in the transaction were not disclosed in the announcement. The current number of shares held by Dogan after the transaction also remains undisclosed.
Cardio Diagnostics Holdings, Inc.(CDIO.US)報告了一筆涉及首席技術官鐵木爾·多安的交易。該交易於 2024 年 1 月 23 日進行。但是,公告中沒有披露有關股票數量、股票性質、交易價格和交易所涉股票總價值的具體細節。交易後多安目前持有的股票數量也仍未公開。
Cardio Diagnostics Holdings, Inc.(CDIO.US)報告了一筆涉及首席技術官鐵木爾·多安的交易。該交易於 2024 年 1 月 23 日進行。但是,公告中沒有披露有關股票數量、股票性質、交易價格和交易所涉股票總價值的具體細節。交易後多安目前持有的股票數量也仍未公開。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。